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Testing of resveratrol microemulsion photostability 
and protective effect against UV induced oxidative stress
Resveratrol is well known for its antioxidant activity and 
susceptibility to ultraviolet radiation. Development of for-
mulations providing improved stability and relevant drug 
delivery of resveratrol is still a challenging task. The aim of 
this study was to determine protective characteristics of for-
mulated microemulsions by evaluating photoisomerization 
of resveratrol and to investigate the effects of resveratrol on 
human keratinocyte cells under oxidative stress caused by 
ultraviolet radiation. Incorporation of resveratrol into micro-
emulsions resulted in increased photostability of active com-
pounds and the results demonstrated that photodegradation 
of resveratrol was significantly delayed. Results of biophar-
maceutical evaluation in vitro demonstrated that up to 60 % 
of resveratrol was released from microemulsions within 6 
hours under a constant release rate profile. In vivo biological 
testing confirmed the ability of resveratrol to protect cells 
from oxidative stress and to increase cell viability. It was 
concluded that microemulsions might be considered in the 
development of UV light sensitive compounds.
Keywords: microemulsion, resveratrol, photostability, Ha-
CaT cells, UVB, oxidative stress
Resveratrol (3,5,4’-trihydroxystilbene, RES) is a naturally occurring polyphenolic com-
pound, which protects cells from oxidative stress (1). Due to its high antioxidant activity, 
resveratrol is considered to have a high potential to be applied in therapy and prophy-
laxis. Interest in this phytoalexin has increased over recent years and its protective effects 
in treatment of skin diseases, such as skin aging or skin cancer, have been confirmed (2). 
Research data demonstrated a high superoxide, hydroxyl, and other radical scavenging 
ability of resveratrol and its ability to suppress production of reactive oxygen species 
(ROS) (3).
Resveratrol ability to penetrate into skin is limited, thus the development of efficient 
carriers is a possible approach to reaching appropriate active compound concentrations in 
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since high compound photosensivity to visible light and UV radiation has been deter-
mined. UV radiation and temperature induce rapid transformation of trans-resveratrol into 
the cis-isomeric form, resulting in decreased biological activity (4). The trans-isoform of 
resveratrol should be protected until its delivery to the site of action in skin tissues.
Physically and chemically stable nanoformulations are thought to provide active sub-
stances with efficient protection from external factors. Application of nanostructured for-
mulations could help overcome the poor solubility of resveratrol and its limited penetra-
tion into the skin (5, 6). Microemulsions (MEs) are known for their ability to incorporate 
high amounts of lipophilic and hydrophilic active compounds and provide a skin penetra-
tion enhancing effect (7). Ease of formulation and thermodynamic stability are other im-
portant advantages of MEs that make them superior to other colloidal systems, e.g. 
nanoparticles, niosomes or liposomes (8). Consequently, it is useful to apply ME for incor-
poration of photolabile compounds (e.g. resveratrol) and suitability of the ME carrier has 
to be confirmed by stability testing and biopharmaceutical characterization of the formu-
lation.
The aim of this study was to evaluate the ability of formulated MEs to protect resve-
ratrol from photoisomerization and to assess their quality after UVB exposure. Also, ME 
irritation potential was evaluated by testing on a human keratinocyte (HaCaT) cell line. 
Non-toxic concentrations of MEs were determined by evaluating cell viability. Protective 
and antioxidant effects of resveratrol on human skin cells under normal conditions and 
under oxidative stress, caused by UVB radiation, were investigated.
EXPERIMENTAL
Materials
Analytical grade trans-resveratrol and chromatography grade acetonitrile and acetic 
acid were obtained from Sigma-Aldrich Chemie GmbH (Germany). Resveratrol was sup-
plied by Naturex (France). MEs were formulated using PEG-8 caprylic/capric glycerides as 
surfactants and polyglyceryl-6-isostearate as cosurfactants, both supplied by Gattefosse 
(France). Ethyl oleate was used as an oily phase in MEs and was purchased from Alfa 
Aesar GmbH & Co KG (Germany). Ultrapure water was produced using a water purifica-
tion system Millipore Simplicity™ (USA). Dimethyl sulfoxide (DMSO) and 96 % ethanol 
were used as solvents for resveratrol and were obtained from Sigma-Aldrich Chemie 
GmbH (Germany) and AB Vilniaus degtinė (Lithuania), respectively. Polyethylene glycol 
(PEG 400) was purchased from Carl Roth GmbH+Co KG (Germany). Trypsin, Dulbecco’s 
modified Eagle’s medium (DMEM), penicillin/streptomycin solution, fetal bovine serum 
(FBS), Hank’s balanced salt solution (HBSS), and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
tetrazolium bromide (MTT) were obtained from Life technologies (USA).
Quantitative determination of trans-resveratrol
Resveratrol was determined in all tested samples by validated high-performance liquid 
chromatography (HPLC) using an Agilent 1260 Infinity capillary LC system (Agilent 
Technologies Inc., USA) with a diode array detector. The Zorbax C18 column (150 × 0.5 mm, 
5 μm) was used for separation of trans- and cis-resveratrol. Separation was performed 
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under isocratic conditions using a 0.5 % aqueous solution of acetic acid (solvents A) and 
acetonitrile (solvent B) in a ratio 75:25 (V/V) as mobile phase. Eluent flow rate was 10 μL 
min–1. UV detection was performed at a 306 nm wavelength. Column temperature was 
maintained at 25 ° C.
Formulation of microemulsions
Composition of MEs was chosen considering our previous results of composition op-
timization, characterization, stability and skin penetration studies, and contained 57 % of 
the surfactant and co-surfactant mixture, 38 % of aqueous phase, and 5 % of oily phase (9). 
Skin penetration studies demonstrated that highest quantities of resveratrol in the skin 
were determined when 2 % resveratrol ME (ME-RES) with surfactant and co-surfactant 
mass ratio 5:1 was applied. Physical properties of ME-RES were defined by evaluating 
droplet size distribution and the mean particle size.
MEs with and without RES were formulated using the oil titration method at room 
temperature. A mixture of surfactant and co-surfactant (5:1, m/m) was added to water un-
der mixing at 1250 rpm for 10 minutes using a magnetic stirrer IKAMAG® C-MAG HS7 
(IKA-Werke GmbH & Co.KG, Germany). Ethyl oleate was added dropwise to the mixture 
under vigorous stirring until transparent and a clear formulation was obtained. ME-RES 
was formulated by dissolving RES in the oily phase and surfactant to produce a 2 % con-
centration of active substance in the finished product (9). ME and ME-RES formation was 
confirmed visually. MEs were allowed to equilibrate for 24 hours keeping formulations at 
ambient temperature.
Characterization of microemulsions
The physical quality of MEs was evaluated by determining the mean droplet size and 
polydispersity index (PDI) of MEs using a Zetasizer Nano ZS particle size analyzer (UK). 
PDI was measured to characterize the droplet size distribution. All formulations were 
analyzed at 25 °C 24 h after their production and measurements were performed in tripli-
cate.
Evaluation of resveratrol photostability
Photostability studies were performed to determine the effect of UVB on the trans-RES 
to cis-RES transformation. Transformation process was evaluated by comparing RES 
 photostability in a 2 % ME-RES and 2 % ethanolic resveratrol solution (RES-control). Stabil-
ity of formulated MEs was evaluated by irradiating ME without resveratrol (ME-control). 
Irradiation of samples was performed in Petri dishes placed at a 20 cm distance from a 
MRL-58 Multiple-Ray UV lamp (Ultra-Violet Products Ltd, UK) and were exposed to the 
light source < 1 mW cm–2 for 4 hours under ambient conditions (4, 10). Irradiance was de-
termined using a UVX radiometer (Ultra-Violet Products Ltd, UK). Aliquots were taken 
from 2 % ME-RES and RES-control at 15, 30, 60, 120, and 240 min, diluted with ethanol, and 
trans- and cis-RES were determined by HPLC. Physical stability of ME-RES and ME-con-
trol was evaluated by measuring the droplet size and PDI applying the dynamic light 
scattering technique after UBV irradiation for 120 and 240 min.
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In vitro release studies
RES release from MEs was studied by measuring diffusion from a dialysis bag (5). 
ME-RES samples (1.00 ± 0.02g) were placed into the pre-swelled dialysis bag (Sigma-Al-
drich Chemie GmbH, Germany). The ends of the bag were fixed with clamps and im-
mersed into 500 mL of dialysis medium. A mixture of purified water and PEG 400 (50:50, 
m/m) was used as acceptor medium and was stirred using a hotplate magnetic stirrer IKA-
MAG® C-MAG HS7 (IKA-Werke GmbH & Co.KG, Germany). Medium temperature was 
kept at 32 ± 0.1 °C. Sink conditions were maintained throughout release studies. 1 mL of 
acceptor medium was removed at time points of 0.5, 1, 2, 4, 6 hours and replaced by the 
same volume of fresh dissolution medium. Withdrawn samples were filtered through 0.20 
μm nylon membrane filters and analyzed by the HPLC method.
Cell lines and cell culture
The immortalized human keratynocyte cell line, HaCaT cells, was obtained from Cell 
Lines Service GmbH (Germany). The cells were seeded and grown in culture flasks with 
DMEM containing 10 % fetal bovine serum (FBS) and 100 U mL–1 penicillin and 100 μg 
mL–1 streptomycin. HaCaT cells were cultured at 37 °C under humidified conditions with 
5 % CO2. The cells were sub-cultured after reaching about 80 % confluence and the medi-
um was changed two or three times per week.
Measurement of cell viability
Cell viability was assessed by the MTT method (11). The cells were seeded into 96-well 
plates at a density of 20,000 cells/well and incubated for 24 h. After incubation, cells were 
treated with different sample solutions: a) ME without added resveratrol (ME-control), b) 
ME-RES, and c) solution of resveratrol in DMSO (RES-control). All the prepared samples 
were diluted using Hank’s balanced salt solution (HBSS). After 24 h of treatment with the 
preparations, DMEM medium was removed and cells were washed twice with HBSS (100 
μL/well). After washing, 180 μL/well HBSS and 20 μL/well MTT (final concentration, 5 mg/
mL) dye were added to each well, and cells were incubated for 2 h at 37 °C under humidi-
fied conditions with 5 % CO2. After that, the dye was removed and DMSO (100 μL/well) 
was added in order to dissolve the purple crystals of formazan formed. The plate with 
solvent was kept in the dark for 15 min. Absorption was measured spectrophotometri-
cally at 550 nm and 620 nm wavelengths using a microplate spectrophotometer (Thermo 
Scientific Multiscan FC, USA). Results of cellular viability were expressed as the percent-
age of untreated control cells. All experiments were repeated three times at least.
Effect of formulations on cell damage caused by UVB
Different doses of UVB irradiation (10, 25, 50, 75 and 100 mJ cm–2) were used to cause 
cell damage and to evaluate the protective effect of tested formulations (ME-control, ME-
RES, RES-control). The cells were seeded into 96-well plates (20,000 cells/well) and incu-
bated for 24 h. After incubation, HaCaT cells were treated with different doses of UVB ir-
radiation to determine the dose-cell viability relationship. Later on, the possible protective 
effect of tested formulations on the irradiated cells was assessed by testing cell viability 
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after UVB irradiation. Tested formulations were added to the HaCaT cells cultivated in 
96-well plates 2 h prior to UVB irradiation (12). Before UVB exposure, the medium was 
removed and cells were washed once with HBSS. The cells were irradiated with UVB using 
a UV lamp (UVP, MRL-58 Multiple-Ray Lamp, USA) after HBSS thin layer addition. Irra-
diation dose was calculated using a UVX Radiometer (UVP, USA). HBSS was removed 
after irradiation. Fresh medium was added to each well and cells were incubated for 24 h. 
Cell viability was determined by the MTT method as described above. Untreated cells and 
UVB irradiated cells without test formulations added were used as controls.
Statistical analysis
All tests were repeated three times at least. The results were expressed as means ± SD. 
Statistically significant difference was determined when p < 0.05. Student’s t-test was used 
to evaluate significant differences in test results. Statistical analysis of experimental data 
was performed using the Microsoft Office Excel and 2013 SPSS software (version 19.0).
RESULTS AND DISCUSSION
Published research data demonstrated limited stability of RES under irradiation with 
UV light, which could cause photodegradation of RES (13). Microemulsions (MEs) were 
formulated to provide a protective effect on RES and minimize possible isomerization. In 
order to evaluate the protective effect of formulated ME on the photostability of RES under 
UVB exposure, the stability of trans-RES in RES-ME and ethanolic solution of RES (RES-
control) was tested. The concentration of trans-RES in tested formulations was 2 %.
Concentration of trans-RES decreased both in ME and in ethanolic solution under 
UVB exposure (Fig. 1). Results of photodegradation studies showed a decrease of trans-RES 
Fig. 1. Stability of 2 % trans-resveratrol in microemulsion (–•–) and ethanolic solution (····) under UV 
irradiation.
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by 83.7 % in ethanolic solution in 4 h. Trans-RES concentration decreased by 39.1 % after 4 
h of UVB exposure when ME-RES formulation was irradiated. The results demonstrated 
that inclusion of RES in ME decreased photoisomerization of RES while concentration of 
trans-RES was approx. 3.2 fold higher. ME provided efficient protection to RES for 1 h 
 under UVB irradiation. Concentration of trans-RES in RES-control was gradually decreas-
ing over all the 4 h of exposure to UVB. Decrease of trans-RES was determined in samples 
collected at 2-h and 4-h time points. The results demonstrated the ability of MEs to provide 
increased physical stability of RES under UVB irradiation compared to ethanolic solution. 
These results could be related to physicochemical characteristics of the active substance 
since lipophilic RES predominantly accumulated in droplets’ interfacial layer and was less 
accessible to UVB radiation. Similar observations were reported when application of nano-
structured formulations (nanocapsules, nanospheres, liposomes, nanostructured lipid 
carriers) decreased RES photodegradation significantly (4, 10).
The effect of UVB irradiation on ME particle size characteristics was evaluated by 
measuring the mean droplet size and PDI before and after UVB exposure. Smaller droplets 
of ME-control were determined compared to droplet size when ME contained RES (Table 
I). The increase in droplet size could be due to incorporation of RES as a fraction of surfac-
tant and co-surfactant should participate in solubilization of RES molecules. Decreased 
availability of surfactant and co-surfactant molecules resulted in a decrease of interfacial 
film surface area and a proportional increase in droplet size. However, the size of ME-RES 
was in an acceptable ME droplet size range. Similar effects of active substances on droplet 
size were reported previously when active substances were incorporated into colloidal 
systems, e.g. microemulsions (14), liposomes (10), nanosuspensions (15). The possibility of 
RES accumulation in the interfacial layer of nanostructure systems has been discussed 
earlier (6). Incorporation of RES into MEs did not affect PDI values of the system compared 
to ME-control and the narrow droplet size distribution indicated homogeneity of formula-
tions.
The results demonstrated increased mean droplet size with increasing exposure to 
UVB. Mean droplet size in ME-RES was 1.7 fold bigger compared to the mean droplet size 
in ME-control before UVB irradiation (0 h). After 4 h of UVB exposure, the mean droplet 
size increased by 37.2 % in ME-RES and by 65.41 % in ME-control compared to the mean 
droplet size before UVB irradiation. This indicates that UV irradiation can induce changes 
in the chemical composition of the interfacial film and lower the surface activity of possi-
bly formed compounds. The presence of RES in the ME interfacial film increases its resis-
tance against the damaging UV effect. Study results demonstrated a decrease in PDI of 
ME-control (from 0.286 to 0.242) and a single peak droplet size distribution pattern. Expo-
Table I. Characteristics of MEs-RES and MEs before and after UVB irradiation
Duration of UVB 
irradiation (h)
ME-RES ME-control
Droplet size (nm) PDI Droplet size (nm) PDI
0 112.5 ± 1.3 0.263 ± 0.008 66.3 ± 0.2 0.286 ± 0.005
2 132.4 ± 2.6 0.301 ± 0.024 – –
4 154.4 ± 2.0 0.316 ± 0.041 109.7 ± 0.7 0.242 ± 0.008
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sure of MEs to UVB resulted in increased PDI and a two-peak droplet size distribution in 
ME-RES, indicating the appearance of bigger droplets (Fig. 2).
Droplet size distribution was investigated to evaluate the physical stability of the car-
rier before and after UVB exposure. Study results demonstrated that 24 h after formulation 
the droplet size in ME-RES ranged from 28.21 to 531.2 nm. Changes of ME-RES droplet size 
were observed after 2 and 4 h of UVB irradiation. After 2 h of UVB exposure, droplet sizes 
were in the ranges of 28.21–396.1 nm and 4145–5560 nm. Droplet size measurements dem-
onstrated the formation of bigger droplets (32.67–458.7 nm and 4145–5560 nm) after 4 h of 
UVB radiation, but the droplet mean size of the second peak did not change. The results 
of intensity measurements demonstrated that the predominating particle fraction in the 
main peak remained the same as before UV irradiation (Fig. 2); however, the appearance 
of a bigger particle peak was identified. The second peak indicates formation of bigger 
particles, which could represent the products of possible coalescence of ME droplets or 
their agglomeration. The applied photon correlation spectroscopy method did not allow 
reliable differentiation of droplets and agglomerates. However, the applied method con-
firmed the presence of bigger particles and pointed to the destabilizing effect of UV irra-
diation on the MEs formulations tested. Evaluation of ME components’ individual suscep-
tibility to UV light could provide information for a better understanding of processes that 
potentially induce changes in MEs. Stabilization of MEs against the UV effect could be 
achieved either by including antioxidants or by using surfactants possessing antioxidant 
properties for interfacial film formation (16).
The ability of the formulated system to release active substances is considered to be an 
important criterion in product characterization and quality evaluation studies. Determina-
tion of the RES release profile provided additional understanding of the distribution of RES 
in ME. RES is considered to have limited solubility in water and it required a modified ac-
ceptor medium compared to water-soluble drugs. As regards solubility characteristics, PEG 
400 was added to acceptor medium to maintain sink conditions throughout the testing pro-
Fig. 2. Effect of UVB irradiation on droplet size distribution in ME-RES.
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cedure. Results of biopharmaceutical evaluation revealed that RES was released at a constant 
speed and the total amount of released RES reached 60.73 % after 6 h. However, the delay of 
RES appearance in acceptor medium in the initial phase of the experiment could be attrib-
uted to the limited diffusion process across the semipermeable membrane and release of 
RES from ME droplets (5). Results of RES release evaluation demonstrated a constant release 
rate over the 6 h of testing. A zero order kinetic model was used to describe release kinetics 
of the drug from the formulated system (R2 = 0.992). Results of drug release studies con-
firmed the suitability of the carrier to incorporate and release RES, and ME-RES formulation 
was considered acceptable for further biological testing.
Effects of ME excipients in their formulation on manifestation of RES biological activ-
ity should be confirmed by biological testing on appropriate cell models. Biological evalu-
ation of the produced formulations was done applying the human keratinocyte (HaCaT) 
cellular model. Different concentrations of ME-control were used to evaluate its potential 
cytotoxicity. No statistically significant difference was established (p > 0.05) between the 
viability of control group cells (untreated cells) and the viability of cells exposed to ME-
control at concentrations of 0.01, 0.05, 0.1, 0.15 and 0.2 %. Exposure of keratinocytes to 0.25 
% or higher concentrations of ME-control resulted in a statistically significant difference 
(p < 0.05) of cell viability compared to the control since the viability of keratinocytes was 
less than 90 %. Considering these results, the 0.15 % concentration of ME was chosen for 
further studies.
Protective effects of formulated systems against oxidative stress damage were evalu-
ated using UVB as inducer of ROS generation. UVB is a major factor in the development of 
skin diseases, particularly skin cancer (3, 12). The viability of UVB affected HaCaT cells 
was evaluated using the MTT method. Five different UVB doses (10, 25, 50, 75, and 100 mJ 
cm–2) were applied to evaluate the effects of UVB irradiation on cell viability (Fig. 3). Study 
results demonstrated that UVB exposure caused a statistically significant p < 0.05) decrease 
of cell viability. Viability evaluation showed that cell viability depends on the UVB dose, 
since its increase resulted in decreased numbers of viable cells. The results in Figure 3 
show a two-fold decrease of HaCaT viable cells after exposure to a 50 mJ cm–2 dose com-
pared to non-irradiated cells. Maximum decrease (75.32 %) was observed after 100 mJ cm–2 
UVB exposure.
Results of the experiment indicated decreased cell survival after UVB irradiation, 
thus different formulations were tested to evaluate their protective potential for HaCaT 
cells. Keratinocytes were pretreated with tested formulations (ME-control, ME-RES, RES-
control) for 2 hours prior irradiation with UVB and the protective effect of RES was evalu-
ated. RES concentration in cell containing wells was 131 μM.
Study results demonstrated that treatment of cells with ME-control and following 
UVB irradiation had no effect on the viability of cells in the tested irradiation range from 
10 mJ cm–2 to 100 mJ cm–2 compared to UVB irradiated cells (Fig. 3). Pretreatment of cells 
with RES, applied in ME (ME-RES) and in solution (RES-control) before UVB exposure, 
resulted in increased HaCaT cell viability. No statistically significant difference was estab-
lished (p > 0.05) between the viability of cells subjected to UVB (UVB-control) and RES 
pretreated cells when radiation doses of 10 and 25 mJ cm–2 were applied. Increased RES 
photoprotection was identified at higher doses of UVB (> 50 mJ cm–2) and cell viability dif-
fered significantly (p < 0.05) compared to UVB irradiated control cells. Protective effect of 
ME-RES was determined when keratinocytes were irradiated with UVB doses ranging 
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from 50 to 100 mJ cm–2 cell and cell viability increased by 27.8–40.1 % compared to UVB-
control. A similar protective effect on cell viability was established when results obtained 
after ME-RES application were compared to ME-control. Application of RES in ME re-
sulted in higher cell viability than RES-control even though differences were not statisti-
cally significant in the UVB irradiation ranges tested. The above findings provide a ratio-
nale for using MEs in the delivery of RES considering increased RES stability in ME and 
delayed release pattern.
These studies also confirmed the photoprotective effect of RES and its ability to reduce 
UVB radiation caused cell death. Protective effects of RES on stressed keratinocytes could 
be associated with its antioxidant activity. Epidermis has a specific binding site for RES, 
thus topical application of RES is considered an effective approach in prevention and treat-
ment of skin diseases (1). The results of this study demonstrate the ability of formulated 
ME to function as an efficient RES delivery system for transporting it into epidermal cells, 
and thus confirms the significant protective effect of RES against oxidative stress.
CONCLUSIONS
MEs are spontaneously forming disperse systems and were formulated as potential 
carriers for delivery of RES into the skin. Physical stability, drug release and biological stud-
ies were performed to determine the suitability of the formulated nanocarrier system. The 
results demonstrated that MEs could protect RES from photoisomerization and ensure the 
stability of RES for up to 1 hour under UVB irradiation. Drug release testing revealed diffu-
sion and gradual release of RES from ME. The effects of RES on skin cells confirmed the 
potential use of this antioxidant as a protective agent to reduce ROS generation and enhance 
Fig. 3. Effect of the presence of resveratrol in applied formulations and of UVB dose on HaCaT cell 
viability.
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cell viability when the cells were subjected to oxidative stress. All these findings indicate 
that the formulated ME-RES could be considered a drug delivery system for RES topical ap-
plication although the increase in droplet size of MEs under UV radiation was determined.
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